Loading...
Loading...
CDC PLACES (2023, crude) estimates 13.9% of adults in Houston have diagnosed diabetes — 1.9 points above the U.S. 12% figure. Census population 2,304,580. Texas Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Houston clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Houston storefront.
Biologic Therapy for Osteoarthritis in Houston, TX for clinics & physicians. Biologic therapy options for… Compliance support & pricing — contact Hawk Medical.
Adult arthritis here is 19.3% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 13.9% of adults in Houston have diagnosed diabetes — 1.9 points above the U.S. 12% figure. Together those PLACES numbers are why a city of 1M+ still needs separate PRP and CTP protocols. osteoarthritis biologic therapy inventory is national; utilization is JH-local.
National Biologic Therapy for Osteoarthritis notes (how the product actually works)JH reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Houston is 13.9% or not. PLACES is planning data. The LCD is the claim.
If you already buy osteoarthritis biologic therapy elsewhere, use this page as a check: homologous-use language, current Novitas Solutions article IDs, and PLACES 13.9% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 13.9% of adults — 1.9 points above the U.S. 12% figure. Obesity is 38%; arthritis is 19.3%. That is place-level BRFSS modeling, not a clinic census and not a Houston trial.
No. They are B2B distribution pages for licensed providers. Patients in Houston should speak with their clinician, not use a distributor URL as care instructions.
Texas is in CMS MAC JH, administered by Novitas Solutions. CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
Use the contact form or book a 15-minute call with Joe Bradley. Bring specialty, monthly wound or joint volume, and whether you bill JH FFS, Advantage, workers’ comp, or cash-pay.
If you operate in Texas and another MAC state, say it on the first call. JH will not port 1:1. We would rather split utilization than watch a sister clinic copy Houston tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Houston, TX.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Houston is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Houston — 1.9 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Texas Part B wound biologics follow this contractor (siblings: AR, CO, LA, MS, NM, OK). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Houston. Useful for joint-program math; still needs a diagnosis and privileging.
No Houston storefront. Joe Bradley is an active practice owner. osteoarthritis biologic therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.